NeurologyLive® Brain Games: September 24, 2023
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is headache and migraine.
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.
Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.
This week's questions include the theme of headache and migraine.
Interested in submitting quiz questions? Contact our associate editorial director, Matt Hoffman, via email:
Which type of headache is characterized by severe, sharp, stabbing, or electric shock-like pain, often occurring in short, recurrent episodes on one side of the head?
What is the first-line acute treatment for a patient with migraine and nausea who does not have contraindications to its use?
Which headache disorder is characterized by chronic, daily headaches that occur for 15 or more days per month for at least three months, often with a background of a primary headache disorder?
How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!
How many questions did you get correct?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
Perispinal Etanercept Shows No Efficacy in Treating Chronic StrokeSeptember 16th 2025
Current Challenges and New Opportunities Ahead for Women in NeurologySeptember 15th 2025
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial UpdateSeptember 15th 2025
